A carregar...
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma
Chondrosarcoma is the most common bone sarcoma in adults. Conventional chondrosarcoma, the commonest histological subtype, is largely resistant to anthracycline-based chemotherapy. There have been anecdotal reports of durable clinical benefit with antiangiogenic agents in this disease. A retrospecti...
Na minha lista:
| Publicado no: | Med Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574947/ https://ncbi.nlm.nih.gov/pubmed/28852958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-017-1030-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|